Products and Services

PPD has added 4,300 sq ft to its GMP biopharmaceuticals and inhalation facility in Athlone, Ireland, the company has announced. The facility, which opened in 2010 and offers a wide range of formulation, development, and analytical testing services for MDIs, DPIs, nasal sprays, and inhalation solutions, is now more than 41,500 sq ft. According to the company's … [Read more...] about PPD expands Athlone laboratory

Propeller Health has closed on a $21.5 million Series C funding round to support expansion of its digital inhaler monitoring platform, the company said. Investors included 3M Ventures, S.R. One, Limited and Hikma Ventures, Safeguard Scientifics, and Social Capital. According to Propeller, the company has experienced rapid growth over the past year "driven by rapid … [Read more...] about Propeller Health raises $21.5 million for expansion of inhaler monitoring platform

Drawing on resources from the Lovelace Respiratory Research Institute (LRRI) and associated companies, a not-for-profit preclinical contract research organization called Lovelace Biomedical is now offering services for pre-clinical development. The new company's services include toxicology, pharmacology, bioanalytical/analytical chemistry, and formulation for a range … [Read more...] about Lovelace launches not-for-profit CRO Lovelace Biomedical

Mast Therapeutics has announced that its subsidiary Aires Pharmaceuticals has signed an agreement with Philips Respironics devices for the supply of I-neb AAD handheld nebulizers for delivery of the company's AIR001 sodium nitrite solution. AIR001 is in Phase 2 development for the treatment of heart failure with preserved ejection fraction (HFpEF). The I-neb … [Read more...] about Mast selects Philips Respironics’ I-neb nebulizer for delivery of AIR001

Drug delivery device design company Coalesce Product Development has announced the opening of a new 375 sq m drug delivery development center in Cambridge, UK as well as several management changes, including the appointment of inhalation expert James Tibbatts as Head of Business Development. The company cited increased demand for its Concept to Clinic product … [Read more...] about Coalesce Product Development announces new development center, management changes

The Intelligent Control Inhaler from 3M Drug Delivery Systems has won the drug delivery devices category of the CPhI Pharma Awards. According to CPhI, the inhaler was recognized "for its approach to addressing patient adherence and competence in Asthma and COPD patients" and is "an intuitive, fully integrated device delivering accurate doses to patients, whilst … [Read more...] about 3M’s Intelligent Control Inhaler wins CPhI award

French device company Biocorp has announced the launch of its Inspair sensor, which it says is "capable of converting any pressurized metered dose inhaler into a connected device." According to the company, the sensor works with adaptors specially designed to fit the mouthpieces of most commonly marketed MDIs for asthma and/or COPD, and it records data on the … [Read more...] about Biocorp launches Inspair inhaler sensor

California-based simulation and modeling software company Simulations Plus has announced that it will join the SimInhale COST (European Cooperation in Science and Technology) Action consortium, which aims to "advance particle designs for improved deposition and interaction with lung tissue, promote realistic computer simulations of particle aerosolization, delivery … [Read more...] about Simulations Plus joins SimInhale consortium

Capsugel has announced that it will add both pilot and commercial scale micronization capacity at a facility in Quakertown, PA which it acquired as part of its acquisition of Powdersize in January 2016. New equipment and suites are expected to be in operation by January 2017. By doubling the company's pilot-scale capacity and adding commercial scale capacity, … [Read more...] about Capsugel expands micronization capacity

Bepak parent company Consort Medical has announced a multi-year agreement with AstraZeneca to supply Bespak's MDI valves and actuators for use in AstraZeneca's Bevespi Aerosphere inhaler. The components for the project, which will be called VAL100, will be manufactured at Bespak's King's Lynn, UK facility. The Bevespi Aerosphere glycopyrrolate/formoterol fumarate … [Read more...] about Bespak to supply components for AstraZeneca’s Bevespi Aerosphere